Comprehensive Eye Care & Vision Correction in Incheon · Multilingual International Concierge
23+ Years Clinical Experience
en-US
Ophthalmology Guide
Am I a Candidate for ICL Surgery? Key Deciding Factors
Wondering if you qualify for ICL surgery? Learn the key screening factors, eye-health checks, and why only a comprehensive exam can decide candidacy.
Schedule a ConsultationAm I a Candidate for ICL Surgery? Key Deciding Factors
Medically reviewed by Dr. Heecheol Pae, Korean Board-Certified Ophthalmologist, Global Ubal Eye Center
What ICL Surgery Is, in Brief
The implantable collamer lens is a phakic intraocular lens. "Phakic" means your natural crystalline lens stays where it is; the implant is added in front of it, in the posterior chamber of the eye, to correct refractive error. This is fundamentally different from laser procedures such as LASIK, which remove and reshape corneal tissue.
Refraction and Degree of Myopia
The starting point of any ICL evaluation is your refraction — a precise measurement of how your eye focuses light and how strong your nearsightedness (myopia) is. Myopia is the condition in which distant objects look blurred because light focuses in front of the retina rather than on it. The degree of myopia matters for two reasons.
Stability of Your Prescription
A single reading of your prescription is not enough; surgeons also want to know that it is stable. If your myopia is still changing noticeably from year to year, correcting it surgically is complicated, because the target keeps moving. A stable refraction over a reasonable period suggests that the correction chosen today is likely to remain appropriate.
Age and the Approved Indication
Age is a concrete deciding factor. The EVO/EVO+ Visian ICL is approved for use in adults ages 21 to 45. This range reflects both the desire for a stable prescription at the lower end and considerations about the natural aging of the eye at the upper end.
Corneal Thickness
Even though the ICL does not reshape the cornea, corneal measurements still matter. Corneal thickness is a key data point in refractive screening generally, and it is one of the factors that helps distinguish who is better suited to a laser procedure versus a lens-based one.
Anterior Chamber Depth
One of the most important anatomical factors specific to ICL is the anterior chamber depth — the space inside the front part of the eye where the lens must sit. Because the implantable collamer lens is placed inside the eye in front of the natural lens, there must be adequate room for it.
Endothelial Cell Count
The corneal endothelium is a single layer of cells on the inner surface of the cornea that keeps the cornea clear by managing fluid. These cells do not regenerate the way many other cells do, and their number is an important measure of corneal health. Endothelial cell count (density) is assessed before ICL surgery for two reasons.
Overall Eye Health and Exclusions
Beyond the numbers, general eye health is decisive. A range of eye conditions can make ICL surgery inadvisable, either because they raise the risk of the procedure or because they need to be treated first. Your ophthalmologist will examine the health of the cornea, the pressure and drainage angle inside the eye, the natural lens, the retina, and more.
The Clinic's Diagnostic Workup
Because so many of these factors are anatomical and cannot be self-assessed, a comprehensive diagnostic workup is the heart of ICL candidacy.
Why Only a Comprehensive Exam Can Decide
It is worth restating plainly: candidacy for ICL surgery is determined at a comprehensive, in-person examination — not from an article, an online quiz, or a phone conversation. The deciding factors are things that must be measured with clinical instruments and interpreted by an ophthalmologist in the context of your whole eye health.
The Bottom Line
- ICL is a posterior-chamber phakic lens placed inside the eye while your natural lens stays in place; it is additive and designed to be removable, which is why its candidacy checklist differs from laser surgery.
- Core deciding factors include your refraction and degree of myopia, a stable prescription, age within the approved EVO indication of 21 to 45, corneal thickness, adequate anterior chamber depth, endothelial cell count, and overall eye health.
- The EVO/EVO+ Visian ICL is U.S. FDA-approved to correct myopia in adults ages 21 to 45, with a toric version for myopic astigmatism.
- This article is educational and not a self-diagnosis tool; several factors that affect candidacy can only be measured with clinical instruments.
- The only way to know if you qualify is a comprehensive in-person exam, where a Global Ubal Eye Center ophthalmologist gathers all of these measurements and explains your options honestly.
Frequently Asked Questions
**Can I tell from my glasses prescription whether I qualify for ICL?**No. Your prescription is one piece of information, but candidacy also depends on measurements you cannot take yourself, such as anterior chamber depth, corneal thickness, and endothelial cell count, plus a full eye-health check. A comprehensive exam is required.
More Articles
Continue reading our ophthalmology guides and vision care insights.
SMILE vs LASIK: Recovery Benchmarks for Vision Correction Care
South Korea has solidified its position as a global epicenter for ophthalmology, with the domestic LASIK and refractive surgery market projected to reach **USD 167.37 million by 2035**, growing at a steady CAGR of 8.54%.
Learn More
Prevalence of Myopia in Korea: The Value of Dream Lens Therapy
The prevalence of myopia among young people in South Korea has reached critical levels, often described as a "myopia epidemic." According to recent data from the **Korean National Health and Nutrition Examination Survey (KNHANES)**, the prevalence of myopia...
Learn More
Multidisciplinary Care: The Future of Korean Pediatric Eye Clinics
The landscape of pediatric eye care in South Korea is shifting rapidly. With nearly **21.9% of Korean children** estimated to be affected by various visual disorders according to nationwide health screenings, the demand for specialized intervention has never...
Learn More